Foghorn Therapeutics (FHTX) has received a new Buy rating, initiated by B.Riley Financial analyst, Kalpit Patel. Kalpit Patel’s rating is based on Foghorn Therapeutics’ innovative approach to ...

B. Riley initiated coverage of Foghorn Therapeutics (FHTX) with a Buy rating and $10 price target. The firm says its investment thesis centers on the company’s strategy to inactivate or degrade ...

Netflix has dated its second SpongeBob SquarePants movie that’ll shift focus onto the evil villain Plankton. It’s due out in March 2025, and here’s everything we know so far. SpongeBob SquarePants has ...

Update 2 of SpongeBob Tower Defense has introduced a new Season Pass from which you can collect precious rewards. Like the battle pass in almost every Roblox experience, this one contains a free ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...